FDA MedWatch - January 2010 FDA Patient Safety News now available

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



Title: FDA MedWatch - January 2010 FDA Patient Safety News now available
MedWatch logo MedWatch - The FDA Safety Information and Adverse Event Reporting Program

FDA Patient Safety News (PSN) is a monthly video news show for healthcare professionals. It covers significant safety alerts, recalls, new product approvals, and offers important tips on protecting patients. Read the complete stories and watch or download the video program at www.fda.gov/psn. You may have already received notification of some of these safety issues through the MedWatch E-list. However, many of these PSN stories contain video footage and demonstrations that may be especially useful to educators in healthcare facilities and academic institutions.

Stories in the January 2010 edition include:

Emergency Use of Peramivir to Treat H1N1
Use of Peramivir is authorized only under certain circumstances, including when the patient is not responding to either oral or inhaled antiviral therapy…

 

Complications with Negative Pressure Wound Therapy

FDA recommendations to help reduce the risk of serious complications with negative pressure wound therapy…

 

Warning Against Nebulizing Relenza Inhalation Powder

Relenza Inhalation Powder, which is used in the treatment and prophylaxis of influenza, is only intended to be inhaled using a Diskhaler…

 

Nationwide Recall of AccuSure Insulin Syringes

These syringe needles may detach from the syringe…

 

Recall of Certain Liquid Glucose Hexokinase Reagents

Laboratories should consider all test results obtained with the recalled reagents to be questionable…

 

Preventing Anaphylactic-type Reactions with Dexferrum

Updated boxed warning about giving patients a test dose and observing them for signs and symptoms of anaphylactic-type reactions every time Dexferrum is administered…

 

Energy Levels in External Biphasic Defibrillators

FDA is looking into reports in which a 200 joule biphasic defibrillator was ineffective in terminating an arrhythmia, whereas a subsequent shock from a 360 joule device resulted in immediate defibrillation or cardioversion…

 

Alert on Philips Avalon Fetal Monitors

While Philips continues to investigate, the company recommends several interim steps to reduce the likelihood of inaccurate readings or their impact…

 

Never Use Parenteral Syringes for Oral Medications

Once a parenteral syringe is filled with a liquid intended for oral use, it can be accidentally connected to an intravenous line, with potentially dangerous consequences…


Manage your FDA Subscriptions:


Fight Flu with Facts! Visit flu.gov. Call 800-232-4636. Text FLU to 87000.

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420


[Index of Archives]     [CDC News]     [NIH News]     [USDA News]     [Steve's Art]     [Camping in Yosemite]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux